arrow_back Back to App

Affordable Insulin Act: Lower Costs for Patients

This act aims to reduce insulin costs for individuals with diabetes. Starting January 1, 2024, health plans cannot apply deductibles or charge more than $35 or 25% of the negotiated price for a 30-day supply of insulin. This is intended to make insulin more accessible and financially predictable for patients.
Key points
Insulin Cost Cap: Insurers cannot charge more than $35 or 25% of the negotiated price for a 30-day supply of insulin.
No Deductibles: Health plans cannot apply deductibles for selected insulin products.
Cost-Sharing Counts: Any insulin cost-sharing payments will count towards annual out-of-pocket maximums.
Effective 2024: Changes apply to health plans beginning on or after January 1, 2024.
Covers Selected Products: The act covers at least one of each dosage form (e.g., vial, pump, inhaler) and type (e.g., rapid-acting, long-acting) of insulin.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_1488
Sponsor: Rep. Craig, Angie [D-MN-2]
Process start date: 2023-03-09
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

Affordable Insulin Now Act

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_1488.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-09.

What are the main provisions?

Key points include:

  • Insulin Cost Cap: Insurers cannot charge more than $35 or 25% of the negotiated price for a 30-day supply of insulin.
  • No Deductibles: Health plans cannot apply deductibles for selected insulin products.
  • Cost-Sharing Counts: Any insulin cost-sharing payments will count towards annual out-of-pocket maximums.
  • Effective 2024: Changes apply to health plans beginning on or after January 1, 2024.
  • Covers Selected Products: The act covers at least one of each dosage form (e.g., vial, pump, inhaler) and type (e.g., rapid-acting, long-acting) of insulin.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Craig, Angie [D-MN-2].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health